Document Detail

Exogenous arginine in sepsis.
MedLine Citation:
PMID:  17713409     Owner:  NLM     Status:  MEDLINE    
Sepsis is a severe condition in critically ill patients and is considered an arginine deficiency state. The rationale for arginine deficiency in sepsis is mainly based on the reduced arginine levels in sepsis that are associated with the specific changes in arginine metabolism related to endothelial dysfunction, severe catabolism, and worse outcome. Exogenous arginine supplementation in sepsis shows controversial results with only limited data in humans and variable results in animal models of sepsis. Since in these studies the severity of sepsis varies but also the route, timing, and dose of arginine, it is difficult to draw a definitive conclusion for sepsis in general without considering the influence of these factors. Enhanced nitric oxide production in sepsis is related to suggested detrimental effects on hemodynamic instability and enhanced oxidative stress. Potential mechanisms for beneficial effects of exogenous arginine in sepsis include enhanced (protein) metabolism, improved microcirculation and organ function, effects on immune function and antibacterial effects, improved gut function, and an antioxidant role of arginine. We recently performed a study indicating that arginine can be given to septic patients without major effects on hemodynamics, suggesting that more studies can be conducted on the effects of arginine supplementation in septic patients.
Yvette C Luiking; Nicolaas E P Deutz
Related Documents :
18800899 - Effect of indian herbal hypoglycemic agents on antioxidant capacity and trace elements ...
16987019 - A wave of reactive oxygen species (ros)-induced ros release in a sea of excitable mitoc...
12606529 - The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 ...
12879409 - Early cell-specific changes in nitric oxide synthases, reactive nitrogen species format...
15796899 - In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalizatio...
15183199 - Evidence for contribution of vascular nad(p)h oxidase to increased oxidative stress in ...
6357849 - Energy fuel and hormonal profile in experimental obesities.
15548809 - Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin rec...
1886889 - Glp-1 and glp-1(7-36) amide: influences on basal and stimulated insulin and glucagon se...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Critical care medicine     Volume:  35     ISSN:  0090-3493     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-23     Completed Date:  2007-11-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S557-63     Citation Subset:  AIM; IM    
Center for Translational Research on Aging & Longevity, Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arginine / administration & dosage,  metabolism*,  therapeutic use*
Critical Illness
Dose-Response Relationship, Drug
Drug Administration Schedule
Nitric Oxide / biosynthesis
Nutritional Support / methods
Oxidative Stress
Sepsis / metabolism*,  therapy*
Reg. No./Substance:
10102-43-9/Nitric Oxide; 74-79-3/Arginine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exogenous glutamine--compensating a shortage?
Next Document:  Use of exogenous arginine in multiple organ dysfunction syndrome and sepsis.